MERCK CAPITAL VENTURES
Merck Capital Ventures invests in companies in various stages of development from the first round of institutional funding to later stage expansion opportunities. The firm does not invest in research based pharmaceutical, vaccine, and biotechnology companies. It seeks to invest in private Internet, commercialization, distribution and delivery of pharmaceuticals, and health care services. The firm typically invests in companies based in the United States and also considers non-United States compa... nies with significant United States operations. It typically invests between $3 million and $8 million. The firm seeks to co-invest and prefers a board representation in its portfolio companies. It also seeks to provide follow-on financing. Merck Capital Ventures, LLC was founded in November 2000 and is based in Woodcliff Lake, New Jersey. Merck Capital Ventures, LLC operates as an investment arm of Merck & Co. Inc.
MERCK CAPITAL VENTURES
Industry:
Biotechnology Finance Venture Capital
Founded:
2000-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Nginx Sitelinks Search Box Yoast WordPress SEO Plugin JsDelivr
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-10-25 | She's Well | Merck Capital Ventures investment in Seed Round - She's Well | 2.1 M USD |
| 2018-08-10 | Artios Pharma | Merck Capital Ventures investment in Series B - Artios Pharma | 65 M GBP |
| 2015-06-08 | Spero Therapeutics | Merck Capital Ventures investment in Series A - Spero Therapeutics | 30 M USD |
| 2012-01-16 | mihealth | Merck Capital Ventures investment in Venture Round - mihealth | N/A |
| 2011-07-13 | HTG Molecular Diagnostics | Merck Capital Ventures investment in Series D - HTG Molecular Diagnostics | 16.2 M USD |
| 2010-01-11 | ImpactRx | Merck Capital Ventures investment in Series E - ImpactRx | 1.2 M USD |
| 2008-11-28 | HTG Molecular Diagnostics | Merck Capital Ventures investment in Series C - HTG Molecular Diagnostics | 2.8 M USD |
| 2008-08-04 | PHT Corporation | Merck Capital Ventures investment in Series F - PHT Corporation | 1.03 M USD |
| 2008-04-21 | VisEn Medical | Merck Capital Ventures investment in Series B - VisEn Medical | 5 M USD |
| 2007-10-08 | HTG Molecular Diagnostics | Merck Capital Ventures investment in Series C - HTG Molecular Diagnostics | 5.62 M USD |
More informations about "Merck Capital Ventures"
M Ventures
M Ventures is the strategic, corporate venture capital fund of Merck KGaA, Darmstadt, Germany, investing in Biotechnology and Technology. We cover the areas of Healthcare drug development, Life Science tools, Electronics and …See details»
M Ventures - Merck
M Ventures is the strategic corporate venture capital fund of Merck, with a dual remit of strategic and financial returns. In 2021, we increased the funds available for investment by an additional Eur 600M to enable more and larger …See details»
Merck Expands Corporate Venture Fund M Ventures …
Dec 8, 2021 Merck, a leading science and technology company, today announced the expansion of its strategic, corporate venture capital arm M …See details»
Merck Capital Ventures investment portfolio | PitchBook
Oct 5, 2017 General Information Company Description Founded in 2000, Merck Capital Ventures was a subsidiary of Merck & Co Inc. based in Woodcliff Lake, New Jersey. The firm …See details»
Merck KGaA steps up VC activity with $677M …
Dec 8, 2021 Merck KGaA is upping its commitment to corporate venture capital with a 600 million euro ($677 million) investment, positioning its VC arm M Ventures to up the number and size of its bets over the ...See details»
M Ventures - Crunchbase Investor Profile & Investments
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas.See details»
Merck Capital Ventures - CB Insights
Nov 15, 2012 About Merck Capital Ventures Merck Capital Ventures is the New Jersey-based corporate venture group of publicly-traded, U.S.-based pharmaceutical firm, Merck & Co. …See details»
Merck Capital Ventures – Investors Database – Unicorn Nest
Summary Merck Capital Ventures is the famous VC, which was founded in 2000. The main office of represented VC is situated in the Woodcliff Lake. The venture was found in North America …See details»
Impact Venture Fund - Merck.com
Through venture capital investments into funds and companies, we seek to address complementary facets of a sustainable and resilient global health ecosystem, including …See details»
Merck Capital Ventures - Investments, Portfolio & Company Exits
Merck Capital Ventures invests in companies in various stages of development from the first round of institutional funding to later stageSee details»
A JOINT VENTURE BETWEEN ONYX EQUITIES AND MACHINE …
NEWARK, N.J., Feb. 16, 2023 /PRNewswire/ -- A Joint Venture between Onyx Equities, LLC and Machine Investment Group, LLC ("the Venture") has acquired Merck Sharp & Dohme LLC …See details»
Demystifying the Merck Global Health Innovation Fund: How …
Jul 19, 2024 Corporate venture capital provides pharmaceutical companies with the means to stay agile, tap into external innovations, and drive growth through strategic investments. In …See details»
How Does Venture Capital Shape Biotech Innovation?
Apr 25, 2025 In new research, Xuelin Li, Sijie Wang, Jiajie Xu, and Xiang Zheng find that the involvement of specialized venture capital firms influences a biotech startup’s drug portfolio by …See details»
M Ventures - EU-Startups
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core …See details»
M Ventures - EMD Group
M Ventures is the strategic corporate venture capital fund of our company, with a dual remit of strategic and financial returns. In 2021, we increased the funds available for investment by an …See details»
Onyx Equities and Machine Investment Group Acquire Former …
Feb 21, 2023 A joint venture between Woodbridge, New Jersey-based Onyx Equities, LLC and Machine Investment Group, LLC acquired Merck Sharp & Dohme LLC (parent: Merck & Co …See details»
M Ventures - EU-Startups
M Ventures is the strategic corporate venture capital fund of Merck KGaA, Darmstadt, Germany. Established in 2009, it manages a fund of €600 million, investing in biotechnology and …See details»
Corporate Venturing - Harvard Business Review
So in 2001 the company launched a corporate venture-capital fund in order to engage with cutting-edge biotech firms when they were just start-ups.See details»
Top Trends in VC: How Talent, Capital & Caution are Redefining …
1 day ago For newer funds, it’s a tough market. LPs are playing it safe, sticking with familiar names and proven track records. Key facts: In Q1 2025, the U.S. venture capital fundraising …See details»
Merck Capital Ventures - Funding, Financials, Valuation & Investors
Merck Capital Ventures invests in companies in various stages of development from the first round of institutional funding to later stageSee details»